Michael Nofi

Michael Nofi currently serves as the Chief Financial Officer at Edgewise Therapeutics, a position held since November 2025. Prior experience includes roles such as Chief Accounting Officer at SpringWorks Therapeutics, where financial operations and team management were directed, and at The Nature's Bounty Co., overseeing global accounting functions. Additional experience includes leadership positions in financial strategy and compliance at Perfumania Holdings, Connor Group, Acorda Therapeutics, and Allergan, demonstrating a strong background in SEC reporting, financial planning, and internal controls. Michael Nofi began a career in finance at PwC, managing audit engagements, and holds a Bachelor of Science in Accounting and an MBA from Villanova University.